Literature DB >> 25525794

Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin.

Silvia F Kluge1, Katharina Mack1, Shilpa S Iyer2, François M Pujol3, Anke Heigele1, Gerald H Learn2, Shariq M Usmani1, Daniel Sauter1, Simone Joas1, Dominik Hotter1, Frederic Bibollet-Ruche2, Lindsey J Plenderleith4, Martine Peeters5, Matthias Geyer6, Paul M Sharp4, Oliver T Fackler3, Beatrice H Hahn7, Frank Kirchhoff8.   

Abstract

Most simian immunodeficiency viruses use their Nef protein to antagonize the host restriction factor tetherin. A deletion in human tetherin confers Nef resistance, representing a hurdle to successful zoonotic transmission. HIV-1 group M evolved to utilize the viral protein U (Vpu) to counteract tetherin. Although HIV-1 group O has spread epidemically in humans, it has not evolved a Vpu-based tetherin antagonism. Here we show that HIV-1 group O Nef targets a region adjacent to this deletion to inhibit transport of human tetherin to the cell surface, enhances virion release, and increases viral resistance to inhibition by interferon-α. The Nef protein of the inferred common ancestor of group O viruses is also active against human tetherin. Thus, Nef-mediated antagonism of human tetherin evolved prior to the spread of HIV-1 group O and likely facilitated secondary virus transmission. Our results may explain the epidemic spread of HIV-1 group O.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25525794      PMCID: PMC4274627          DOI: 10.1016/j.chom.2014.10.002

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  35 in total

1.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

2.  Tetherin: holding on and letting go.

Authors:  Daniel Sauter; Anke Specht; Frank Kirchhoff
Journal:  Cell       Date:  2010-04-30       Impact factor: 41.582

Review 3.  Non-M variants of human immunodeficiency virus type 1.

Authors:  Thomas Mourez; François Simon; Jean-Christophe Plantier
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo.

Authors:  Rachel A Liberatore; Paul D Bieniasz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

5.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

6.  Reacquisition of Nef-mediated tetherin antagonism in a single in vivo passage of HIV-1 through its original chimpanzee host.

Authors:  Nicola Götz; Daniel Sauter; Shariq M Usmani; Joëlle V Fritz; Christine Goffinet; Anke Heigele; Matthias Geyer; Frederic Bibollet-Ruche; Gerald H Learn; Oliver T Fackler; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2012-09-13       Impact factor: 21.023

7.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

Authors:  Daniel Sauter; Michael Schindler; Anke Specht; Wilmina N Landford; Jan Münch; Kyeong-Ae Kim; Jörg Votteler; Ulrich Schubert; Frederic Bibollet-Ruche; Brandon F Keele; Jun Takehisa; Yudelca Ogando; Christina Ochsenbauer; John C Kappes; Ahidjo Ayouba; Martine Peeters; Gerald H Learn; George Shaw; Paul M Sharp; Paul Bieniasz; Beatrice H Hahn; Theodora Hatziioannou; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

8.  Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.

Authors:  Ravindra K Gupta; Petra Mlcochova; Annegret Pelchen-Matthews; Sarah J Petit; Giada Mattiuzzo; Deenan Pillay; Yasuhiro Takeuchi; Mark Marsh; Greg J Towers
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

9.  A tail of Tetherin: how pandemic HIV-1 conquered the world.

Authors:  Ravindra K Gupta; Greg J Towers
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

10.  Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein.

Authors:  Daniel Sauter; Daniel Unterweger; Michael Vogl; Shariq M Usmani; Anke Heigele; Silvia F Kluge; Elisabeth Hermkes; Markus Moll; Edward Barker; Martine Peeters; Gerald H Learn; Frederic Bibollet-Ruche; Joëlle V Fritz; Oliver T Fackler; Beatrice H Hahn; Frank Kirchhoff
Journal:  PLoS Pathog       Date:  2012-12-20       Impact factor: 6.823

View more
  41 in total

1.  HIV-1 Nef hijacks clathrin coats by stabilizing AP-1:Arf1 polygons.

Authors:  Qing-Tao Shen; Xuefeng Ren; Rui Zhang; Il-Hyung Lee; James H Hurley
Journal:  Science       Date:  2015-10-23       Impact factor: 47.728

2.  HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.

Authors:  Denis M Tebit; Hamish Patel; Annette Ratcliff; Elodie Alessandri; Joseph Liu; Crystal Carpenter; Jean-Christophe Plantier; Eric J Arts
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-16       Impact factor: 2.205

3.  The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild.

Authors:  Anke Heigele; Dorota Kmiec; Kerstin Regensburger; Simon Langer; Lukas Peiffer; Christina M Stürzel; Daniel Sauter; Martine Peeters; Massimo Pizzato; Gerald H Learn; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2016-09-14       Impact factor: 21.023

4.  TIM-mediated inhibition of HIV-1 release is antagonized by Nef but potentiated by SERINC proteins.

Authors:  Minghua Li; Abdul A Waheed; Jingyou Yu; Cong Zeng; Hui-Yu Chen; Yi-Min Zheng; Amin Feizpour; Björn M Reinhard; Suryaram Gummuluru; Steven Lin; Eric O Freed; Shan-Lu Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-06       Impact factor: 11.205

5.  HIV-1 Nefs Are Cargo-Sensitive AP-1 Trimerization Switches in Tetherin Downregulation.

Authors:  Kyle L Morris; Cosmo Z Buffalo; Christina M Stürzel; Elena Heusinger; Frank Kirchhoff; Xuefeng Ren; James H Hurley
Journal:  Cell       Date:  2018-07-26       Impact factor: 41.582

6.  Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain.

Authors:  Katharina Mack; Kathrin Starz; Daniel Sauter; Simon Langer; Frederic Bibollet-Ruche; Gerald H Learn; Christina M Stürzel; Marie Leoz; Jean-Christophe Plantier; Matthias Geyer; Beatrice H Hahn; Frank Kirchhoff
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

7.  Structural Basis for Tetherin Antagonism as a Barrier to Zoonotic Lentiviral Transmission.

Authors:  Cosmo Z Buffalo; Christina M Stürzel; Elena Heusinger; Dorota Kmiec; Frank Kirchhoff; James H Hurley; Xuefeng Ren
Journal:  Cell Host Microbe       Date:  2019-08-22       Impact factor: 21.023

Review 8.  Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication.

Authors:  Andrew Soper; Guillermo Juarez-Fernandez; Hirofumi Aso; Miyu Moriwaki; Eri Yamada; Yusuke Nakano; Yoshio Koyanagi; Kei Sato
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

Review 9.  Tetherin/BST-2: Restriction Factor or Immunomodulator?

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; Mario L Santiago
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

10.  Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.

Authors:  Thomas van Stigt Thans; Janet I Akko; Annika Niehrs; Wilfredo F Garcia-Beltran; Laura Richert; Christina M Stürzel; Christopher T Ford; Hui Li; Christina Ochsenbauer; John C Kappes; Beatrice H Hahn; Frank Kirchhoff; Glòria Martrus; Daniel Sauter; Marcus Altfeld; Angelique Hölzemer
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.